media – Page 484 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Senators Write to GlaxoSmithKline to Boost Shingrix Supply

As a result of the high demand for GlaxoSmithKline's new shingles vaccine, Shingrix, two U.S. senators have urged the pharma giant to boost inventory levels on facing a shortage in the supplies even after the company established their "fair and equitable" process to ship Shingrix doses.
- Source: FiercePharma
- 820
- July 10, 2018
Company Insight GlaxoSmithKline shingles Shingrix vaccine
Boehringer Ingelheim BioXcellence Expands China Plant, adds Fill-Finish Line.

Boehringer Ingelheim is expanding its $77 million contract biologics China plant, making a notable bet that the kind of contract services it offers elsewhere will be a big draw to China too.
- Source: FiercePharma
- 735
- July 10, 2018
Boehringer Ingelheim Company Insight
Viscofan to Trial Stem Cell Implant for Severe Cardiac Insufficiency

Viscofan BioEngineering, a German medical products manufacturer is to conduct a Phase I clinical trial of its stem cell implant, VB-C01, designed to treat severe cardiac insufficiencies, on receiving a green light from the Spanish Agency for Medicines (AEMPS).
- Source: Verdict Medical Devices
- 755
- July 10, 2018
cardiovascular Researches stem cells
DHA Announces Free Hepatitis C Screening & Treatment in Dubai

Hepatitis C is caused by the Hepatitis C virus (HCV), which affects the liver. The World Health Organization (WHO) reported that around 399,000 people die every year due to Hepatitis C throughout the world. Hepatitis C leads to cirrhosis and liver cancer since it is diagnosed only at a late stage.
- Source: GulfNews
- 777
- July 10, 2018
hepatitis C Market Views Policies UAE
DHA Announces Free Hepatitis C Screening & Treatment in Dubai

The Dubai Health Authority (DHA) announced free Hepatitis C screening and treatment under the health plan of the Dubai Mandatory Health Insurance Scheme on 9 July 2018.
- Source: GulfNews
- 248
- July 10, 2018
Red Wine and Green Tea could Treat Congenital Inborn Metabolic Diseases

A research team from Tel Aviv University suggested that red wine and green tea could treat certain congenital metabolic diseases, by blocking toxic metabolite formations. Since people with inborn metabolic disorders are born with a defective gene, it leads to a critical enzyme deficiency. Since there is no cure, many patients with congenital metabolic disorders are required to follow a lifelong strict diet.
- Source: Science Daily
- 553
- July 10, 2018
metabolic disease Researches
Smart Bandage to Enhance Wound Healing

The smart bandages used in this research work were designed with heating elements and thermo-responsive drug carriers in order to deliver timely treatments. It combines both temperature and pH sensors to track the signs of infection.
- Source: The Verge
- 1,413
- July 10, 2018
medical device products Researches
Intel Survey that Supports Artificial Intelligence in Healthcare Settings

A recent survey from Intel revealed that health system decision-makers have considered artificial intelligence as a new element of life. Still, many people are anxious as to whether it could provide safe care.
- Source: Healthcare IT
- 626
- July 10, 2018
AI Market Views
FDA Rebukes Chinese API maker Sichuan Friendly Pharmaceutical in Warning Letter

The FDA sent a warning letter to Sichuan Friendly Pharmaceutical after listing it in the import alert list due to its abysmal performance during a fall inspection. The FDA was not pleased with the manufacturing methods it saw at the Chinese API maker’s facility.
- Source: FiercePharma
- 742
- July 9, 2018
FDA pharmaceutical company Policies
Rise in Shares for Biogen, Eisai as Alzheimer’s Drug Succeeds in Mid-Stage Trial.

In a breakthrough finding, revealed through the final analysis of a mid-stage trial, Japanese pharmaceutical firm, Eisai Co and Biogen Inc’s drug for Alzheimer’s proved beneficial for patients who received the highest dose.
- Source: Reuters
- 698
- July 9, 2018
Alzheimer's disease Eisai Market Views

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.